Rui Ding1, Shilei Lin, Daojun Chen. 1. School of Public Health, Anhui Medical University, Meishan Road 81, 230032 Hefei, Anhui Province, China. kilthy11@yahoo.com
Abstract
INTRODUCTION: NAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism is found to have a lower enzymatic activity, which may result in increased incidence of several kinds of carcinomas including colorectal cancer. Results from published studies on the association of NQO1 rs1800566 genetic polymorphism with the risk of colorectal cancer are inconsistent. We performed a meta-analysis to summarize the possible association. MATERIALS AND METHODS: All eligible published studies were searched from PubMed and Elsevier ScienceDirect. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were analyzed for additive, dominant, and recessive models to assess the association using fixed- or random-effect model. RESULTS: We identified 12 case-control studies that include 5,525 cases and 6,272 controls for the present meta-analysis. Significant associations between NQO1 rs1800566 genetic polymorphism and risk of colorectal cancer were observed in additive (OR = 1.09, 95% CI = 1.02-1.16, p = 0.009) and dominant models (OR = 1.12, 95% CI = 1.04-1.21, p = 0.004 for TT + CT vs. CC). Moreover, in the subgroup analysis based on ethnicity, significant associations were observed in Caucasians but not in Asians. CONCLUSIONS: This meta-analysis provided evidence that NQO1 rs1800566 genetic polymorphism was associated with increased risk of colorectal cancer and that the T allele probably acts as an important risk factor.
INTRODUCTION:NAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism is found to have a lower enzymatic activity, which may result in increased incidence of several kinds of carcinomas including colorectal cancer. Results from published studies on the association of NQO1rs1800566 genetic polymorphism with the risk of colorectal cancer are inconsistent. We performed a meta-analysis to summarize the possible association. MATERIALS AND METHODS: All eligible published studies were searched from PubMed and Elsevier ScienceDirect. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were analyzed for additive, dominant, and recessive models to assess the association using fixed- or random-effect model. RESULTS: We identified 12 case-control studies that include 5,525 cases and 6,272 controls for the present meta-analysis. Significant associations between NQO1rs1800566 genetic polymorphism and risk of colorectal cancer were observed in additive (OR = 1.09, 95% CI = 1.02-1.16, p = 0.009) and dominant models (OR = 1.12, 95% CI = 1.04-1.21, p = 0.004 for TT + CT vs. CC). Moreover, in the subgroup analysis based on ethnicity, significant associations were observed in Caucasians but not in Asians. CONCLUSIONS: This meta-analysis provided evidence that NQO1rs1800566 genetic polymorphism was associated with increased risk of colorectal cancer and that the T allele probably acts as an important risk factor.
Authors: M J Lafuente; X Casterad; M Trias; C Ascaso; R Molina; A Ballesta; S Zheng; J K Wiencke; A Lafuente Journal: Carcinogenesis Date: 2000-10 Impact factor: 4.944
Authors: Lifang Hou; Nilanjan Chatterjee; Wen-Yi Huang; Andrea Baccarelli; Sunita Yadavalli; Meredith Yeager; Robert S Bresalier; Stephen J Chanock; Neil E Caporaso; Bu-Tian Ji; Joel L Weissfeld; Richard B Hayes Journal: Carcinogenesis Date: 2005-02-24 Impact factor: 4.944
Authors: R D Traver; T Horikoshi; K D Danenberg; T H Stadlbauer; P V Danenberg; D Ross; N W Gibson Journal: Cancer Res Date: 1992-02-15 Impact factor: 12.701
Authors: Simon Papillon-Cavanagh; Nicolas De Jay; Nehme Hachem; Catharina Olsen; Gianluca Bontempi; Hugo J W L Aerts; John Quackenbush; Benjamin Haibe-Kains Journal: J Am Med Inform Assoc Date: 2013-01-26 Impact factor: 4.497
Authors: Jolien J M Freriksen; Jody Salomon; Hennie M J Roelofs; Rene H M Te Morsche; Jos W J van der Stappen; Polat Dura; Ben J M Witteman; Martin Lacko; Wilbert H M Peters Journal: J Hum Genet Date: 2014-05-15 Impact factor: 3.172